BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 25500295)

  • 1. An unusual cause of acute kidney injury due to oxalate nephropathy in systemic scleroderma.
    Mascio HM; Joya CA; Plasse RA; Baker TP; Flessner MF; Nee R
    Clin Nephrol; 2015 Aug; 84(2):111-5. PubMed ID: 25500295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An unusual cause of acute renal failure in systemic sclerosis.
    Mpofu S; Rhodes JM; Mpofu CM; Moots RJ
    Ann Rheum Dis; 2003 Dec; 62(12):1133-4. PubMed ID: 14644848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxalate nephropathy in systemic sclerosis: Case series and review of the literature.
    Ligon CB; Hummers LK; McMahan ZH
    Semin Arthritis Rheum; 2015 Dec; 45(3):315-20. PubMed ID: 26239907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Case of Oxalate Nephropathy: When a Single Cause Is Not Crystal Clear.
    Marques S; Santos S; Fremin K; Fogo AB
    Am J Kidney Dis; 2017 Nov; 70(5):722-724. PubMed ID: 28739328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxalate nephropathy in a diabetic patient after gastric by-pass.
    Moutzouris DA; Skaneli G; Margellos V; Apostolou T; Petraki C; Nikolopoulou N
    Clin Nephrol; 2011 Feb; 75 Suppl 1():16-9. PubMed ID: 21269587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Granulomatous interstitial nephritis after a jejunoileal bypass: an ultrastructural and histochemical study.
    Verani R; Nasir M; Foley R
    Am J Nephrol; 1989; 9(1):51-5. PubMed ID: 2719063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small intestinal bacterial overgrowth in patients suffering from scleroderma: clinical effectiveness of its eradication.
    Parodi A; Sessarego M; Greco A; Bazzica M; Filaci G; Setti M; Savarino E; Indiveri F; Savarino V; Ghio M
    Am J Gastroenterol; 2008 May; 103(5):1257-62. PubMed ID: 18422815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small Intestinal Transit Time Is Delayed in Small Intestinal Bacterial Overgrowth.
    Roland BC; Ciarleglio MM; Clarke JO; Semler JR; Tomakin E; Mullin GE; Pasricha PJ
    J Clin Gastroenterol; 2015 Aug; 49(7):571-6. PubMed ID: 25319735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Images: chronic intestinal pseudoobstruction and the "hide-bound" bowel sign.
    Hokama A; Ihama Y; Kishimoto K; Yara S; Kinjo F; Fujita J
    Arthritis Rheum; 2007 May; 56(5):1724. PubMed ID: 17469174
    [No Abstract]   [Full Text] [Related]  

  • 10. "Green Smoothie Cleanse" Causing Acute Oxalate Nephropathy.
    Makkapati S; D'Agati VD; Balsam L
    Am J Kidney Dis; 2018 Feb; 71(2):281-286. PubMed ID: 29203127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Semiquantitative assessment of the intestinal motility in chronic intestinal pseudo-obstruction in systemic sclerosis and mixed connective tissue disease by Sitzmarks capsule.
    Nagashima T; Iwamoto M; Minota S
    Mod Rheumatol; 2006; 16(5):330-1. PubMed ID: 17039319
    [No Abstract]   [Full Text] [Related]  

  • 12. Chronic idiopathic intestinal pseudo-obstruction with malabsorption, a scleroderma-like disorder.
    Lukie BE; Sanders MG
    Can Med Assoc J; 1973 Dec; 109(12):1222-7. PubMed ID: 4758595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastrointestinal motility disorder assessment in systemic sclerosis.
    Savarino E; Mei F; Parodi A; Ghio M; Furnari M; Gentile A; Berdini M; Di Sario A; Bendia E; Bonazzi P; Scarpellini E; Laterza L; Savarino V; Gasbarrini A
    Rheumatology (Oxford); 2013 Jun; 52(6):1095-100. PubMed ID: 23382360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxalate nephropathy in an elderly patient with newly diagnosed celiac disease - a case report.
    Zijlstra HW; Stegeman CA
    BMC Nephrol; 2023 Jun; 24(1):189. PubMed ID: 37370009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pseudo-obstruction and other obstructive disorders.
    Snape WJ
    Clin Gastroenterol; 1982 Sep; 11(3):593-608. PubMed ID: 6754172
    [No Abstract]   [Full Text] [Related]  

  • 16. [Involvement of the small intestine during progressive systemic sclerosis. Presentation of a case and review of the literature].
    Papi A; Gonçalves CS; Arantes M; Perazzo S; Hércules HC; Santos JL; Pórto JA; Fraga Filho C
    Hospital (Rio J); 1968 Dec; 74(6):1779-98. PubMed ID: 5305606
    [No Abstract]   [Full Text] [Related]  

  • 17. Pathology and Epidemiology of Oxalate Nephrosis in Cheetahs.
    Mitchell EP; Church ME; Nemser SM; Yakes BJ; Evans ER; Reimschuessel R; Lemberger K; Thompson PN; Terio KA
    Vet Pathol; 2017 Nov; 54(6):977-985. PubMed ID: 28891390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute oxalate nephropathy associated with orlistat, a gastrointestinal lipase inhibitor.
    Singh A; Sarkar SR; Gaber LW; Perazella MA
    Am J Kidney Dis; 2007 Jan; 49(1):153-7. PubMed ID: 17185156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scleroderma with intestinal involvement: fatal in two of a kindred.
    Strosberg JM; Peck B; Harris ED
    J Rheumatol; 1977; 4(1):46-52. PubMed ID: 886552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid renal deterioration secondary to oxalate in a patient with diabetic gastroenteropathy.
    Crook ED; Cook WJ; Bergman SM
    Am J Kidney Dis; 1995 Jul; 26(1):68-71. PubMed ID: 7611271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.